Other studies showed PERK activation in brain tissues from Alzheimer’s (AD) patients, and the authors suggested an important role for the UPR in the initial stages of AD neurodegeneration (Hoozemans et al., 2005, 2009). This evidence concerns the gene EIF2AK3 and Alzheimer disease.